Liam Ratcliffe  Non-executive Chairman

Liam is a General Partner at New Leaf Venture Partners, focussing on biopharmaceutical investing. He previously served as SVP and Development Head for Pfizer Neuroscience, as well as Worldwide Head of Clinical Research and Development. Additional …

Read more

Kate Bingham  Non-executive Director

Kate joined SVLS in 1991.

She currently serves or has served on the boards of companies in the UK, US, Ireland, Sweden and Germany. She has been responsible for past investments in Affinium, Alantos, Auxilium, Convergence, ESBATech, EUSA, …

Read more

Martin Edwards  Non-executive Director

Martin joined Novo A/S in 2003 working out of their London office. He is chairman of the board of directors of Vantia Therapeutics Ltd, and a member of the board of directors of Epsilon-3 Bio Ltd, Funxional Therapeutics Ltd, KalVista Pharmaceut…

Read more

Sam Williams  Observer

Sam has 18 years' experience in the biotech industry, both as a top-ranked equity analyst in the City and, subsequently, as an entrepreneur and chief executive. From 2002 to 2007 he worked at Lehman Brothers where he was ranked the number one Eu…

Read more

Stephen Shuttleworth  Chief Operating Officer and Chief Scientific Officer

Stephen joined Karus as CSO in 2008, and in 2017 was appointed COO. He is the founding scientist of Karus’s PI3K-p110β/δ and HDAC6 therapeutic programs. He has a successful track record, gained over 23 years, in the design and dev…

Read more